Literature DB >> 2453555

Reaction patterns of monoclonal antibodies to DNA.

R J Smeenk1, K Brinkman, H G van den Brink, A A Westgeest.   

Abstract

Starting with spleen cells from MRL/lpr, NZB/W, and graft-vs-host-diseased mice, we prepared a total of 57 hybridomas that produce antibodies to DNA. Using various approaches, we studied the avidity of these monoclonals in relation to their behavior in four anti-DNA assays. From the results obtained, we postulate that on the basis of anti-DNA avidity the anti-DNA ELISA, the polyethylene glycol assay, the indirect immunofluorescence test on Crithidia luciliae, and the Farr assay (in this order) detect a decreasing amount of anti-dsDNA, the Farr assay being strictly selective for high avidity anti-dsDNA. mAb selected by the anti-DNA ELISA generally were of a low avidity toward DNA. Using cardiolipin and dextran sulfate, a polyanion that bears a resemblance in charge to DNA, we studied the cross-reactivity of the monoclonals. A total of 6 of the 57 monoclonals were found to cross-react with cardiolipin, and 26 with dextran sulfate. We observed an inverse relationship between anti-DNA avidity and cross-reactivity: the lower the avidity of the antibody, the more cross-reactive it is. Based on these findings, we postulate that it is at least questionable whether low avidity, cross-reactive (monoclonal) anti-DNA is representative for the anti-DNA found in patients with SLE.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453555

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Time between onset of apoptosis and release of nucleosomes from apoptotic cells: putative implications for systemic lupus erythematosus.

Authors:  A E M van Nieuwenhuijze; T van Lopik; R J T Smeenk; L A Aarden
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

2.  IgG anti-cardiolipin antibodies in murine lupus.

Authors:  A E Gharavi; R C Mellors; K B Elkon
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

3.  DNA and factor VII-activating protease protect against the cytotoxicity of histones.

Authors:  Gerben Marsman; Helen von Richthofen; Ingrid Bulder; Florea Lupu; Jan Hazelzet; Brenda M Luken; Sacha Zeerleder
Journal:  Blood Adv       Date:  2017-11-30

Review 4.  A comparison of assays used for the detection of antibodies to DNA.

Authors:  R Smeenk; K Brinkman; H van den Brink; T Swaak
Journal:  Clin Rheumatol       Date:  1990-03       Impact factor: 2.980

5.  Evidence for direct anti-heparin-sulphate reactivity in sera of SLE patients.

Authors:  K Pirner; A Rascu; W Nürnberg; A Rubbert; J R Kalden; B Manger
Journal:  Rheumatol Int       Date:  1994       Impact factor: 2.631

6.  Murine monoclonal antibodies to DNA. A comparison of MRL/lpr NZB/W and chronically graft-versus-host-diseased mice.

Authors:  K Brinkman; A van Dam; H van den Brink; R M Termaat; J Berden; R Smeenk
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

Review 7.  Anti-dsDNA: choice of assay in relation to clinical value.

Authors:  R J Smeenk; H G van den Brink; K Brinkman; R M Termaat; J H Berden; A J Swaak
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

8.  Histones interact with anionic phospholipids with high avidity; its relevance for the binding of histone-antihistone immune complexes.

Authors:  L F Pereira; F M Marco; R Boimorto; A Caturla; A Bustos; E G De la Concha; J L Subiza
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

9.  Anti-nucleosome antibodies complexed to nucleosomal antigens show anti-DNA reactivity and bind to rat glomerular basement membrane in vivo.

Authors:  C Kramers; M N Hylkema; M C van Bruggen; R van de Lagemaat; H B Dijkman; K J Assmann; R J Smeenk; J H Berden
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  IgG human monoclonal anti-DNA autoantibodies from patients with systemic lupus erythematosus.

Authors:  T H Winkler; S Jahn; J R Kalden
Journal:  Clin Exp Immunol       Date:  1991-09       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.